KR20140037803A - 의료 질환 치료용 장치, 시스템 및 방법 - Google Patents
의료 질환 치료용 장치, 시스템 및 방법 Download PDFInfo
- Publication number
- KR20140037803A KR20140037803A KR1020137018221A KR20137018221A KR20140037803A KR 20140037803 A KR20140037803 A KR 20140037803A KR 1020137018221 A KR1020137018221 A KR 1020137018221A KR 20137018221 A KR20137018221 A KR 20137018221A KR 20140037803 A KR20140037803 A KR 20140037803A
- Authority
- KR
- South Korea
- Prior art keywords
- nerve
- stimulation
- trigeminal
- trigeminal nerve
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 147
- 238000011282 treatment Methods 0.000 title claims description 53
- 210000003901 trigeminal nerve Anatomy 0.000 claims abstract description 382
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 327
- 210000005036 nerve Anatomy 0.000 claims abstract description 224
- 230000000638 stimulation Effects 0.000 claims abstract description 220
- 201000010099 disease Diseases 0.000 claims abstract description 165
- 230000002123 temporal effect Effects 0.000 claims abstract description 105
- 210000003792 cranial nerve Anatomy 0.000 claims abstract description 9
- 210000001186 vagus nerve Anatomy 0.000 claims description 236
- 208000035475 disorder Diseases 0.000 claims description 162
- 210000002216 heart Anatomy 0.000 claims description 134
- 210000004556 brain Anatomy 0.000 claims description 99
- 230000007383 nerve stimulation Effects 0.000 claims description 81
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 73
- 230000000694 effects Effects 0.000 claims description 70
- 206010016256 fatigue Diseases 0.000 claims description 70
- 230000011514 reflex Effects 0.000 claims description 63
- 210000001328 optic nerve Anatomy 0.000 claims description 53
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 51
- 230000004913 activation Effects 0.000 claims description 51
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims description 51
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 50
- 230000004054 inflammatory process Effects 0.000 claims description 49
- 208000008589 Obesity Diseases 0.000 claims description 48
- 235000020824 obesity Nutrition 0.000 claims description 48
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims description 47
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims description 46
- 208000029560 autism spectrum disease Diseases 0.000 claims description 46
- 230000000747 cardiac effect Effects 0.000 claims description 45
- 230000007958 sleep Effects 0.000 claims description 45
- 206010061218 Inflammation Diseases 0.000 claims description 44
- 208000010125 myocardial infarction Diseases 0.000 claims description 43
- 230000004936 stimulating effect Effects 0.000 claims description 42
- 230000007160 gastrointestinal dysfunction Effects 0.000 claims description 41
- 230000023597 hemostasis Effects 0.000 claims description 41
- 206010012289 Dementia Diseases 0.000 claims description 40
- 206010042434 Sudden death Diseases 0.000 claims description 39
- 230000000241 respiratory effect Effects 0.000 claims description 36
- 230000033228 biological regulation Effects 0.000 claims description 35
- 206010022437 insomnia Diseases 0.000 claims description 33
- 206010060800 Hot flush Diseases 0.000 claims description 32
- 230000017531 blood circulation Effects 0.000 claims description 31
- 208000009205 Tinnitus Diseases 0.000 claims description 29
- 230000003542 behavioural effect Effects 0.000 claims description 29
- 231100000886 tinnitus Toxicity 0.000 claims description 29
- 206010012335 Dependence Diseases 0.000 claims description 28
- 208000020706 Autistic disease Diseases 0.000 claims description 27
- 208000028017 Psychotic disease Diseases 0.000 claims description 27
- 210000003076 trochlear nerve Anatomy 0.000 claims description 27
- 206010003658 Atrial Fibrillation Diseases 0.000 claims description 26
- 206010003805 Autism Diseases 0.000 claims description 26
- 206010019280 Heart failures Diseases 0.000 claims description 26
- 206010049418 Sudden Cardiac Death Diseases 0.000 claims description 26
- 210000000467 autonomic pathway Anatomy 0.000 claims description 26
- 210000000613 ear canal Anatomy 0.000 claims description 26
- 208000019622 heart disease Diseases 0.000 claims description 26
- 238000009826 distribution Methods 0.000 claims description 25
- 208000033830 Hot Flashes Diseases 0.000 claims description 24
- 208000022531 anorexia Diseases 0.000 claims description 24
- 206010061428 decreased appetite Diseases 0.000 claims description 24
- 208000011117 substance-related disease Diseases 0.000 claims description 24
- 208000011580 syndromic disease Diseases 0.000 claims description 24
- 206010006895 Cachexia Diseases 0.000 claims description 23
- 206010015037 epilepsy Diseases 0.000 claims description 23
- 206010033799 Paralysis Diseases 0.000 claims description 22
- 206010040047 Sepsis Diseases 0.000 claims description 22
- 208000034972 Sudden Infant Death Diseases 0.000 claims description 22
- 206010042440 Sudden infant death syndrome Diseases 0.000 claims description 22
- 206010047700 Vomiting Diseases 0.000 claims description 22
- 210000003710 cerebral cortex Anatomy 0.000 claims description 22
- 201000006549 dyspepsia Diseases 0.000 claims description 22
- 230000002496 gastric effect Effects 0.000 claims description 22
- 201000003152 motion sickness Diseases 0.000 claims description 22
- 206010010774 Constipation Diseases 0.000 claims description 21
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 21
- 206010012735 Diarrhoea Diseases 0.000 claims description 21
- 208000014540 Functional gastrointestinal disease Diseases 0.000 claims description 21
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 21
- 208000006673 asthma Diseases 0.000 claims description 21
- 201000008937 atopic dermatitis Diseases 0.000 claims description 21
- 208000006454 hepatitis Diseases 0.000 claims description 21
- 231100000283 hepatitis Toxicity 0.000 claims description 21
- 208000003243 intestinal obstruction Diseases 0.000 claims description 21
- 230000002980 postoperative effect Effects 0.000 claims description 21
- 230000009747 swallowing Effects 0.000 claims description 21
- 201000006474 Brain Ischemia Diseases 0.000 claims description 20
- 206010008120 Cerebral ischaemia Diseases 0.000 claims description 20
- 208000019505 Deglutition disease Diseases 0.000 claims description 20
- 208000032928 Dyslipidaemia Diseases 0.000 claims description 20
- 208000030814 Eating disease Diseases 0.000 claims description 20
- 208000019454 Feeding and Eating disease Diseases 0.000 claims description 20
- 208000017170 Lipid metabolism disease Diseases 0.000 claims description 20
- 206010003246 arthritis Diseases 0.000 claims description 20
- 206010008118 cerebral infarction Diseases 0.000 claims description 20
- 206010012601 diabetes mellitus Diseases 0.000 claims description 20
- 235000014632 disordered eating Nutrition 0.000 claims description 20
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims description 20
- 208000001797 obstructive sleep apnea Diseases 0.000 claims description 20
- 230000002567 autonomic effect Effects 0.000 claims description 19
- 210000003462 vein Anatomy 0.000 claims description 19
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 18
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 18
- 238000002512 chemotherapy Methods 0.000 claims description 18
- 208000021090 palsy Diseases 0.000 claims description 18
- 230000035515 penetration Effects 0.000 claims description 18
- 230000001105 regulatory effect Effects 0.000 claims description 17
- 208000012902 Nervous system disease Diseases 0.000 claims description 16
- 208000025966 Neurological disease Diseases 0.000 claims description 16
- 230000001037 epileptic effect Effects 0.000 claims description 15
- 210000000256 facial nerve Anatomy 0.000 claims description 14
- 230000008482 dysregulation Effects 0.000 claims description 13
- 238000005259 measurement Methods 0.000 claims description 12
- 230000002093 peripheral effect Effects 0.000 claims description 12
- 230000003213 activating effect Effects 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 208000019901 Anxiety disease Diseases 0.000 claims description 9
- 208000000059 Dyspnea Diseases 0.000 claims description 9
- 206010013975 Dyspnoeas Diseases 0.000 claims description 9
- 238000004891 communication Methods 0.000 claims description 9
- 230000003044 adaptive effect Effects 0.000 claims description 8
- 230000004064 dysfunction Effects 0.000 claims description 8
- 206010016825 Flushing Diseases 0.000 claims description 7
- 235000005911 diet Nutrition 0.000 claims description 6
- 230000000977 initiatory effect Effects 0.000 claims description 6
- 210000003205 muscle Anatomy 0.000 claims description 6
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- 230000001771 impaired effect Effects 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 claims description 3
- 230000000378 dietary effect Effects 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 238000001228 spectrum Methods 0.000 claims description 2
- 210000003582 temporal bone Anatomy 0.000 claims description 2
- 210000002972 tibial nerve Anatomy 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 claims 2
- 206010029897 Obsessive thoughts Diseases 0.000 claims 1
- 230000004007 neuromodulation Effects 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 210000004273 ophthalmic nerve Anatomy 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 230000002146 bilateral effect Effects 0.000 abstract description 19
- 230000001815 facial effect Effects 0.000 abstract description 8
- 102100024547 Tensin-1 Human genes 0.000 description 48
- 230000001965 increasing effect Effects 0.000 description 21
- 208000024891 symptom Diseases 0.000 description 20
- 230000008901 benefit Effects 0.000 description 18
- 230000008035 nerve activity Effects 0.000 description 18
- 230000001953 sensory effect Effects 0.000 description 17
- 230000004044 response Effects 0.000 description 16
- 206010003119 arrhythmia Diseases 0.000 description 15
- 210000003952 cochlear nucleus Anatomy 0.000 description 15
- 239000011148 porous material Substances 0.000 description 14
- 206010040880 Skin irritation Diseases 0.000 description 13
- 238000002600 positron emission tomography Methods 0.000 description 13
- 230000036556 skin irritation Effects 0.000 description 13
- 231100000475 skin irritation Toxicity 0.000 description 13
- 210000001061 forehead Anatomy 0.000 description 12
- 210000002442 prefrontal cortex Anatomy 0.000 description 12
- 230000006793 arrhythmia Effects 0.000 description 11
- 210000000133 brain stem Anatomy 0.000 description 11
- 210000004126 nerve fiber Anatomy 0.000 description 11
- 230000037361 pathway Effects 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- 230000001515 vagal effect Effects 0.000 description 11
- 210000003484 anatomy Anatomy 0.000 description 10
- 230000034994 death Effects 0.000 description 10
- 231100000517 death Toxicity 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 230000007012 clinical effect Effects 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 208000020016 psychiatric disease Diseases 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000001154 acute effect Effects 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 208000024714 major depressive disease Diseases 0.000 description 8
- 210000000653 nervous system Anatomy 0.000 description 8
- 230000001537 neural effect Effects 0.000 description 8
- 210000003625 skull Anatomy 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 230000006399 behavior Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 210000003128 head Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 201000000980 schizophrenia Diseases 0.000 description 7
- 206010021143 Hypoxia Diseases 0.000 description 6
- 230000036506 anxiety Effects 0.000 description 6
- 230000001149 cognitive effect Effects 0.000 description 6
- 230000007954 hypoxia Effects 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 230000001936 parietal effect Effects 0.000 description 6
- 230000035807 sensation Effects 0.000 description 6
- 235000019615 sensations Nutrition 0.000 description 6
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 5
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000002635 electroconvulsive therapy Methods 0.000 description 5
- 210000001508 eye Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000007726 management method Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000009245 menopause Effects 0.000 description 5
- 229960002748 norepinephrine Drugs 0.000 description 5
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 5
- 230000001734 parasympathetic effect Effects 0.000 description 5
- 208000028173 post-traumatic stress disease Diseases 0.000 description 5
- 230000002889 sympathetic effect Effects 0.000 description 5
- 230000002861 ventricular Effects 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 208000030886 Traumatic Brain injury Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000003935 attention Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000007177 brain activity Effects 0.000 description 4
- 210000000860 cochlear nerve Anatomy 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000001054 cortical effect Effects 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 208000028867 ischemia Diseases 0.000 description 4
- 210000004228 maxillary nerve Anatomy 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000000926 neurological effect Effects 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- 208000019116 sleep disease Diseases 0.000 description 4
- 210000001103 thalamus Anatomy 0.000 description 4
- 230000009529 traumatic brain injury Effects 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 208000003098 Ganglion Cysts Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 208000009668 Neurobehavioral Manifestations Diseases 0.000 description 3
- 208000005400 Synovial Cyst Diseases 0.000 description 3
- 208000001871 Tachycardia Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 206010000891 acute myocardial infarction Diseases 0.000 description 3
- 230000037424 autonomic function Effects 0.000 description 3
- 208000029028 brain injury Diseases 0.000 description 3
- 230000003727 cerebral blood flow Effects 0.000 description 3
- 230000001713 cholinergic effect Effects 0.000 description 3
- 210000003477 cochlea Anatomy 0.000 description 3
- 208000010877 cognitive disease Diseases 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000003001 depressive effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000004709 eyebrow Anatomy 0.000 description 3
- 210000005153 frontal cortex Anatomy 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000002698 mandibular nerve Anatomy 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000000324 neuroprotective effect Effects 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 210000002741 palatine tonsil Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 230000002739 subcortical effect Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 206010003591 Ataxia Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010050337 Cerumen impaction Diseases 0.000 description 2
- 241001074130 Cryptotis parva Species 0.000 description 2
- 206010012239 Delusion Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000012661 Dyskinesia Diseases 0.000 description 2
- 208000014094 Dystonic disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010017999 Gastrointestinal pain Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000019022 Mood disease Diseases 0.000 description 2
- 206010054048 Postoperative ileus Diseases 0.000 description 2
- 208000020114 Schizophrenia and other psychotic disease Diseases 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 206010049447 Tachyarrhythmia Diseases 0.000 description 2
- 201000004810 Vascular dementia Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 230000003556 anti-epileptic effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 230000037007 arousal Effects 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 208000013404 behavioral symptom Diseases 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000006931 brain damage Effects 0.000 description 2
- 231100000874 brain damage Toxicity 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 210000002939 cerumen Anatomy 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 231100000868 delusion Toxicity 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000010118 dystonia Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 210000000627 locus coeruleus Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 230000004112 neuroprotection Effects 0.000 description 2
- 230000002474 noradrenergic effect Effects 0.000 description 2
- 238000007427 paired t-test Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000007310 pathophysiology Effects 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- 230000009076 regulation of hemostasis Effects 0.000 description 2
- 238000013548 repetitive transcranial magnetic stimulation Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 231100000075 skin burn Toxicity 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 230000003238 somatosensory effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 230000000946 synaptic effect Effects 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 230000004797 therapeutic response Effects 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 210000000427 trigeminal ganglion Anatomy 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 208000003663 ventricular fibrillation Diseases 0.000 description 2
- 206010047302 ventricular tachycardia Diseases 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 description 1
- OJSXICLEROKMBP-FFUDWAICSA-N 869705-22-6 Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 OJSXICLEROKMBP-FFUDWAICSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 208000036640 Asperger disease Diseases 0.000 description 1
- 201000006062 Asperger syndrome Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 206010008748 Chorea Diseases 0.000 description 1
- 208000000532 Chronic Brain Injury Diseases 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010011903 Deafness traumatic Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 208000001613 Gambling Diseases 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 102000012004 Ghrelin Human genes 0.000 description 1
- 101800001586 Ghrelin Proteins 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 102100037907 High mobility group protein B1 Human genes 0.000 description 1
- 101001025337 Homo sapiens High mobility group protein B1 Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 206010023203 Joint destruction Diseases 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000001796 Melanocortin 4 receptors Human genes 0.000 description 1
- 108010008364 Melanocortins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 208000019430 Motor disease Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000002946 Noise-Induced Hearing Loss Diseases 0.000 description 1
- 101800000590 Obestatin Proteins 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000935974 Paralichthys dentatus Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010034158 Pathological gambling Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010037218 Psychopathic personality Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 208000006289 Rett Syndrome Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 description 1
- 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002891 anorexigenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000005735 apoptotic response Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000025748 atypical depressive disease Diseases 0.000 description 1
- 210000003926 auditory cortex Anatomy 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 208000025307 bipolar depression Diseases 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000001159 caudate nucleus Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 208000012601 choreatic disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011833 dog model Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 210000000883 ear external Anatomy 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000020595 eating behavior Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000105 enteric nervous system Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003054 facial bone Anatomy 0.000 description 1
- -1 femoline Chemical compound 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000004055 fourth ventricle Anatomy 0.000 description 1
- 210000001652 frontal lobe Anatomy 0.000 description 1
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000008140 language development Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002865 melanocortin Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 229960001165 modafinil Drugs 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000001423 neocortical effect Effects 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000007433 nerve pathway Effects 0.000 description 1
- 230000003767 neural control Effects 0.000 description 1
- 230000007372 neural signaling Effects 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 230000001703 neuroimmune Effects 0.000 description 1
- 230000008555 neuronal activation Effects 0.000 description 1
- 230000008062 neuronal firing Effects 0.000 description 1
- 230000003557 neuropsychological effect Effects 0.000 description 1
- 238000011457 non-pharmacological treatment Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000009958 parasympathetic pathway Effects 0.000 description 1
- 230000009543 pathological alteration Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 230000002360 prefrontal effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000001176 projection neuron Anatomy 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002582 psychostimulating effect Effects 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000015355 regulation of circadian sleep/wake cycle, sleep Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000031893 sensory processing Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 201000006152 substance dependence Diseases 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001927 transneuronal effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000019649 trigeminal effects Nutrition 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 210000000836 trigeminal nuclei Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36064—Epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
- A61N1/36085—Eating disorders or obesity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
- A61N1/36089—Addiction or withdrawal from substance abuse such as alcohol or drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
- A61N1/36096—Mood disorders, e.g. depression, anxiety or panic disorder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/361—Phantom sensations, e.g. tinnitus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Developmental Disabilities (AREA)
- Social Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Electrotherapy Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Finger-Pressure Massage (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42301110P | 2010-12-14 | 2010-12-14 | |
| US61/423,011 | 2010-12-14 | ||
| US201161440784P | 2011-02-08 | 2011-02-08 | |
| US61/440,784 | 2011-02-08 | ||
| US201161445505P | 2011-02-22 | 2011-02-22 | |
| US61/445,505 | 2011-02-22 | ||
| US201161479787P | 2011-04-27 | 2011-04-27 | |
| US61/479,787 | 2011-04-27 | ||
| PCT/US2011/065002 WO2012082960A2 (en) | 2010-12-14 | 2011-12-14 | Devices, systems and methods for the treatment of medical disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140037803A true KR20140037803A (ko) | 2014-03-27 |
Family
ID=46245359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020137018221A Ceased KR20140037803A (ko) | 2010-12-14 | 2011-12-14 | 의료 질환 치료용 장치, 시스템 및 방법 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20140135886A1 (https=) |
| EP (1) | EP2651496A4 (https=) |
| JP (5) | JP6130789B2 (https=) |
| KR (1) | KR20140037803A (https=) |
| AU (2) | AU2011343763B2 (https=) |
| CA (1) | CA2821981C (https=) |
| WO (1) | WO2012082960A2 (https=) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101525450B1 (ko) * | 2014-08-01 | 2015-06-03 | (주)와이브레인 | 전기 자극 장치 |
| KR20170132236A (ko) * | 2015-03-30 | 2017-12-01 | 세팔리 테크놀로지 에스피알엘 | 삼차 신경의 경피 전기 자극을 위한 장치 |
| WO2019164076A1 (ko) * | 2018-02-23 | 2019-08-29 | 주식회사 아모랩 | 펄스 자기장을 이용한 미주신경 자극 방법 및 장치 |
| US11110273B2 (en) | 2014-08-01 | 2021-09-07 | Y-Brain Inc. | Electrical stimulation device |
| WO2022114621A1 (ko) * | 2020-11-30 | 2022-06-02 | 서울대학교산학협력단 | 부정맥 치료 장치 및 상기 부정맥 치료 장치를 이용하여 사용자의 부정맥을 치료하는 방법 |
| US11433234B2 (en) | 2017-05-19 | 2022-09-06 | Cefaly Technology Sprl | External trigeminal nerve stimulation for the acute non-invasive treatment of migraine attacks |
| KR102546063B1 (ko) | 2022-06-15 | 2023-06-21 | 주식회사 뉴로그린 | 자극 인가 장치 |
Families Citing this family (121)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
| US11351363B2 (en) * | 2005-11-10 | 2022-06-07 | Electrocore, Inc. | Nerve stimulation devices and methods for treating cardiac arrhythmias |
| US12343530B2 (en) | 2006-05-18 | 2025-07-01 | Paras Holdings, Llc | Device and implantation system for electrical stimulation of biological systems |
| US9020597B2 (en) | 2008-11-12 | 2015-04-28 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
| US11577077B2 (en) * | 2006-10-09 | 2023-02-14 | Endostim, Inc. | Systems and methods for electrical stimulation of biological systems |
| US20150224310A1 (en) * | 2006-10-09 | 2015-08-13 | Endostim, Inc. | Device and Implantation System for Electrical Stimulation of Biological Systems |
| US9724510B2 (en) * | 2006-10-09 | 2017-08-08 | Endostim, Inc. | System and methods for electrical stimulation of biological systems |
| US9345879B2 (en) * | 2006-10-09 | 2016-05-24 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
| US8588880B2 (en) | 2009-02-16 | 2013-11-19 | Masimo Corporation | Ear sensor |
| US11229790B2 (en) * | 2013-01-15 | 2022-01-25 | Electrocore, Inc. | Mobile phone for treating a patient with seizures |
| KR101749605B1 (ko) | 2009-10-05 | 2017-06-21 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | 신경계통 이상증상 및 신경질환의 치료를 위한 시스템, 장치 및 방법 |
| US11717681B2 (en) | 2010-03-05 | 2023-08-08 | Endostim, Inc. | Systems and methods for treating gastroesophageal reflux disease |
| US8447404B2 (en) | 2010-03-05 | 2013-05-21 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
| WO2012075192A2 (en) | 2010-11-30 | 2012-06-07 | The Regents Of The University Of California | Pulse generator for cranial nerve stimulation |
| KR20140037803A (ko) | 2010-12-14 | 2014-03-27 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | 의료 질환 치료용 장치, 시스템 및 방법 |
| JP6559395B2 (ja) * | 2010-12-14 | 2019-08-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 医学的障害の治療のための、頭蓋外に埋め込み可能なシステム |
| EP3308830A1 (en) | 2011-04-14 | 2018-04-18 | Endostim, Inc. | Systems and methods for treating gastroesophageal reflux disease |
| US9925367B2 (en) | 2011-09-02 | 2018-03-27 | Endostim, Inc. | Laparoscopic lead implantation method |
| CN104736197A (zh) | 2012-08-23 | 2015-06-24 | 恩多斯提姆公司 | 用于生物系统的电刺激的装置和植入系统 |
| US10485972B2 (en) | 2015-02-27 | 2019-11-26 | Thync Global, Inc. | Apparatuses and methods for neuromodulation |
| US10814131B2 (en) | 2012-11-26 | 2020-10-27 | Thync Global, Inc. | Apparatuses and methods for neuromodulation |
| US10537703B2 (en) | 2012-11-26 | 2020-01-21 | Thync Global, Inc. | Systems and methods for transdermal electrical stimulation to improve sleep |
| CN204147427U (zh) | 2012-11-26 | 2015-02-11 | 塞恩克公司 | 可穿戴的皮肤电刺激设备 |
| US9440070B2 (en) | 2012-11-26 | 2016-09-13 | Thyne Global, Inc. | Wearable transdermal electrical stimulation devices and methods of using them |
| US20240316342A1 (en) * | 2013-01-15 | 2024-09-26 | Electrocore, Inc. | Non-invasive nerve stimulation with mobile software application |
| US9498619B2 (en) | 2013-02-26 | 2016-11-22 | Endostim, Inc. | Implantable electrical stimulation leads |
| EP2968917A1 (en) * | 2013-03-11 | 2016-01-20 | Ohio State Innovation Foundation | Systems for treating anxiety and anxiety-associated disorders |
| CN105324150B (zh) * | 2013-06-28 | 2018-04-27 | Koc大学 | 电刺激装置 |
| US10293161B2 (en) | 2013-06-29 | 2019-05-21 | Thync Global, Inc. | Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state |
| WO2014210595A1 (en) | 2013-06-29 | 2014-12-31 | Thync, Inc. | Transdermal electrical stimulation devices and methods for modifying or inducing cognitive state |
| US9042991B2 (en) * | 2013-08-14 | 2015-05-26 | Syntilla Medical LLC | Implantable head mounted neurostimulation system for head pain |
| US12311114B2 (en) | 2013-08-30 | 2025-05-27 | Neuromod Devices Limited | Method and apparatus for treating a neurological disorder |
| CN105848708A (zh) | 2013-09-03 | 2016-08-10 | 恩多斯蒂姆股份有限公司 | 电刺激疗法中的电极极性切换的方法和系统 |
| WO2015042365A1 (en) * | 2013-09-20 | 2015-03-26 | Dana-Farber Cancer Institute, Inc. | Electro-stimulation systems, methods, and apparatus for treating pain |
| US10960215B2 (en) | 2013-10-23 | 2021-03-30 | Nuxcel, Inc. | Low profile head-located neurostimulator and method of fabrication |
| US12569683B2 (en) | 2013-10-23 | 2026-03-10 | Shiratronics, Inc. | Implantable head located radiofrequency coupled neurostimulation system for head pain |
| EP3071279B1 (en) * | 2013-11-18 | 2021-09-08 | The Regents of the University of California | Device, system and method for reducing headache pain |
| JP6487144B2 (ja) * | 2013-12-20 | 2019-03-20 | 国立大学法人福井大学 | 愛着障害の判定方法 |
| WO2015131093A1 (en) | 2014-02-27 | 2015-09-03 | Thync, Inc. | Methods and apparatuses for user control of neurostimulation |
| EP3148639A4 (en) | 2014-05-17 | 2018-04-18 | Cerevast Medical Inc. | Methods and apparatuses for the application of ensemble waveforms using transdermal neurostimulation |
| US9333334B2 (en) | 2014-05-25 | 2016-05-10 | Thync, Inc. | Methods for attaching and wearing a neurostimulator |
| KR20170063440A (ko) | 2014-05-25 | 2017-06-08 | 하이인 에쿼티 인베스트먼트 펀드 엘.피. | 웨어러블 경피 신경자극기들 |
| JP6345494B2 (ja) * | 2014-06-04 | 2018-06-20 | 日本光電工業株式会社 | リハビリテーション支援システム |
| AU2016277603B2 (en) * | 2014-06-13 | 2019-05-30 | Neuvana, LLC. | Transcutaneous electrostimulator and methods for electric stimulation |
| US10130809B2 (en) | 2014-06-13 | 2018-11-20 | Nervana, LLC | Transcutaneous electrostimulator and methods for electric stimulation |
| US9782584B2 (en) * | 2014-06-13 | 2017-10-10 | Nervana, LLC | Transcutaneous electrostimulator and methods for electric stimulation |
| US10155113B2 (en) * | 2014-07-20 | 2018-12-18 | Qian Xia | Neural physiological apparatus for wakefulness |
| DE102014010882A1 (de) * | 2014-07-27 | 2016-01-28 | Cerbomed Gmbh | Vorrichtung zur Aufbringung eines transkutanen elektrischen Stimulationsreizes |
| WO2016064843A1 (en) | 2014-10-20 | 2016-04-28 | Indiana University Research & Technology Corporation | System and methods for non-invasively monitoring autonomic nerve activity using skin |
| EP3220999A2 (en) | 2014-11-17 | 2017-09-27 | Endostim, Inc. | Implantable electro-medical device programmable for improved operational life |
| EP3229892B1 (en) | 2014-12-09 | 2023-07-05 | Esh, Mordechay | Non-invasive device for treating gastro-esophageal reflux disease |
| WO2016109851A1 (en) | 2015-01-04 | 2016-07-07 | Thync, Inc. | Methods and apparatuses for transdermal stimulation of the outer ear |
| US11534608B2 (en) | 2015-01-04 | 2022-12-27 | Ist, Llc | Methods and apparatuses for transdermal stimulation of the outer ear |
| US10258788B2 (en) | 2015-01-05 | 2019-04-16 | Thync Global, Inc. | Electrodes having surface exclusions |
| EP3302682A1 (en) | 2015-05-29 | 2018-04-11 | Cerevast Medical Inc. | Methods and apparatuses for transdermal electrical stimulation |
| CA3029308A1 (en) * | 2015-06-22 | 2016-12-29 | Research Foundation Of The City University Of New York | Method and apparatus for modulation of effector organs |
| US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
| CN107647847A (zh) * | 2016-07-26 | 2018-02-02 | 纽沃凯生物科技（深圳）有限公司 | 睡眠深度监测方法和睡眠深度监测仪 |
| US9956405B2 (en) | 2015-12-18 | 2018-05-01 | Thyne Global, Inc. | Transdermal electrical stimulation at the neck to induce neuromodulation |
| WO2017106878A1 (en) | 2015-12-18 | 2017-06-22 | Thync Global, Inc. | Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state |
| GB2548148B (en) * | 2016-03-10 | 2019-01-02 | Ford Global Tech Llc | A transcranial neurostimulation system for a vehicle |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US10646708B2 (en) | 2016-05-20 | 2020-05-12 | Thync Global, Inc. | Transdermal electrical stimulation at the neck |
| EP3468658B1 (en) * | 2016-06-10 | 2022-07-27 | Cakmak, Yusuf Ozgur | Electro-stimulation device for innervation of the external ear canal |
| IL266176B (en) * | 2016-10-25 | 2022-08-01 | Brainsway Ltd | Device and method for predicting healing outcome |
| US11819683B2 (en) | 2016-11-17 | 2023-11-21 | Endostim, Inc. | Modular stimulation system for the treatment of gastrointestinal disorders |
| WO2019157103A1 (en) * | 2016-11-17 | 2019-08-15 | Endostim, Inc. | Electrical stimulation system for the treatment of gastrointestinal disorders |
| US20180229041A1 (en) * | 2017-02-14 | 2018-08-16 | Verily Life Sciences Llc | Optimizing neuromodulation stimulation parameters using blood parameter sensing |
| US12053626B2 (en) | 2017-04-06 | 2024-08-06 | Endostim, Inc. | Surface electrodes |
| CN106861043A (zh) * | 2017-04-17 | 2017-06-20 | 郑州大学 | 动物群体协同行为的便携式神经调控系统 |
| JP2020525252A (ja) * | 2017-06-26 | 2020-08-27 | ヴォルソ コープ | 交感神経および交感神経の活動に影響を与えて治療効果を得るための末梢神経刺激装置 |
| EP3684463B1 (en) | 2017-09-19 | 2025-05-14 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| WO2019116028A1 (en) * | 2017-12-11 | 2019-06-20 | Galvani Bioelectronics Limited | Treatment and prevention of cardiac dysfunction |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US20210031044A1 (en) * | 2018-03-20 | 2021-02-04 | Mayo Foundation For Medical Education And Research | Cognitive and memory enhancement systems and methods |
| WO2019203850A1 (en) * | 2018-04-20 | 2019-10-24 | The Feinstein Institute For Medical Research | Systems and methods for delivering non-invasive neuromodulation to reduce the effects of shock and traumatic brain injury in animals and humans and to prolong life |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| WO2019209969A1 (en) | 2018-04-24 | 2019-10-31 | Thync Global, Inc. | Streamlined and pre-set neuromodulators |
| CN112512626B (zh) * | 2018-05-18 | 2025-09-26 | Musc研究发展基金会 | 非侵入式脑神经疗法 |
| UA131534U (uk) * | 2018-05-23 | 2019-01-25 | Микола Вікторович Чухраєв | Пристрій для корекції психічних розладів і релаксації |
| CN113382683A (zh) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | 改善睡眠的系统和方法 |
| WO2020068830A1 (en) | 2018-09-24 | 2020-04-02 | Vivek Sharma | Auricular nerve stimulation to address patient disorders, and associated systems and methods |
| US11260229B2 (en) * | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| US11623088B2 (en) | 2018-12-10 | 2023-04-11 | Spark Biomedical, Inc. | Devices and methods for the treatment of substance use disorders |
| US10695568B1 (en) | 2018-12-10 | 2020-06-30 | Spark Biomedical, Inc. | Device and method for the treatment of substance use disorders |
| US12502527B2 (en) | 2018-12-10 | 2025-12-23 | Spark Biomedical, Inc. | Devices and methods for treating stress and improving alertness using electrical stimulation |
| US11351370B2 (en) * | 2018-12-10 | 2022-06-07 | Spark Biomedical, Inc. | Devices and methods for treating cognitive dysfunction and depression using electrical stimulation |
| US10967182B2 (en) | 2018-12-10 | 2021-04-06 | Spark Biomedical, Inc. | Devices and methods for reducing inflammation using electrical stimulation |
| EP3893988B1 (en) * | 2018-12-13 | 2025-03-12 | LivaNova USA, Inc. | Neuromodulation system for auto-immune and inflammatory disorders |
| US12465718B2 (en) | 2019-01-18 | 2025-11-11 | Ist, Llc | Methods and devices for modulation of integrated neural networks to influence composite sensory processes |
| JP7493702B2 (ja) * | 2019-02-27 | 2024-06-03 | 伊藤超短波株式会社 | 電流刺激装置 |
| USD916300S1 (en) * | 2019-02-28 | 2021-04-13 | Helius Medical, Inc | Non-invasive neurostimulation device |
| USD907221S1 (en) * | 2019-02-28 | 2021-01-05 | Helius Medical, Inc | Non-invasive neurostimulation device |
| US12558146B2 (en) | 2019-04-11 | 2026-02-24 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| CN110123342B (zh) * | 2019-04-17 | 2021-06-08 | 西北大学 | 一种基于脑电波的网瘾检测方法及系统 |
| US11911620B2 (en) | 2019-07-22 | 2024-02-27 | Ismail Mohammed Yousif Musallam | Neuromodulation for treatment of brain and eye strokes and/or acute dysregulated reduced cerebral or ocular blood flow |
| JP7493700B2 (ja) * | 2019-07-26 | 2024-06-03 | 伊藤超短波株式会社 | 顎関節治療器 |
| US11241574B2 (en) | 2019-09-11 | 2022-02-08 | Bose Corporation | Systems and methods for providing and coordinating vagus nerve stimulation with audio therapy |
| US11235156B2 (en) | 2019-09-11 | 2022-02-01 | Bose Corporation | Wearable audio device with vagus nerve stimulation |
| EP4054407B1 (en) * | 2019-11-08 | 2026-04-29 | United Therapeutics Corp. | Stimulation devices and systems |
| US11969250B2 (en) | 2019-11-14 | 2024-04-30 | Mayo Foundation For Medical Education And Research | Scalable multi-resolution electrode array for sensing and stimulating the brain |
| WO2021216071A1 (en) * | 2020-04-23 | 2021-10-28 | Advanced Bionics Ag | Tinnitus treatment with a cochlear implant system |
| BR112022022112A2 (pt) | 2020-05-04 | 2022-12-13 | Btl Healthcare Technologies As | Dispositivo para tratamento não assistido do paciente |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| CN113941088B (zh) * | 2020-07-17 | 2025-07-29 | 纽罗西格玛公司 | 用于三叉神经刺激的脉冲发生器 |
| US20230330411A1 (en) * | 2020-08-28 | 2023-10-19 | Neurive Co., Ltd. | Close-contact type nerve stimulator |
| WO2022045403A1 (ko) * | 2020-08-28 | 2022-03-03 | 고려대학교 산학협력단 | 맞춤형 신경 자극기 |
| WO2022221644A2 (en) * | 2021-04-16 | 2022-10-20 | Texas Medical Center | Systems and methods for stimulating two or more nerve branches |
| US11365854B1 (en) | 2021-09-24 | 2022-06-21 | E. Mishan & Sons, Inc. | Solar light with positionable panels |
| WO2023147401A1 (en) * | 2022-01-26 | 2023-08-03 | The Neurocognitive & Behavioral Institute | Electrical signal delivery device |
| US12017068B2 (en) * | 2022-05-27 | 2024-06-25 | Spark Biomedical, Inc. | Devices and methods for treating motion sickness using electrical stimulation |
| KR102815467B1 (ko) | 2022-06-02 | 2025-06-02 | 주식회사 케이티앤지 | 뇌 자극 장치 및 이를 포함하는 뇌 자극 시스템 |
| US12390640B2 (en) | 2023-02-21 | 2025-08-19 | Spark Biomedical, Inc. | Electrical stimulation methods and devices for improving blood management |
| US12029893B1 (en) | 2023-06-14 | 2024-07-09 | Spark Biomedical, Inc. | Wearable auricular neurostimulator and methods of use |
| WO2025014499A1 (en) * | 2023-07-13 | 2025-01-16 | Neurosigma, Inc. | Functional near-infrared spectroscopy and external nerve stimulation for screening and treatment of neuropsychiatric and neurological disorders |
| WO2025227198A1 (en) * | 2024-05-03 | 2025-11-06 | Parasym Ltd | Neuromodulation platform |
| US12582820B2 (en) | 2024-07-05 | 2026-03-24 | Spark Biomedical, Inc. | Neurostimulation therapy for treating uterine bleeding |
| US20260097225A1 (en) | 2024-10-08 | 2026-04-09 | Btl Medical Solutions A.S. | Devices and methods for application of a magnetic field to the nervous system |
Family Cites Families (113)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3279468A (en) | 1963-05-14 | 1966-10-18 | Vine Sidney Le | Electrotherapeutic facial mask apparatus |
| US3709228A (en) | 1971-01-07 | 1973-01-09 | D Barker | Apparatus for facial stimulation |
| US4233986A (en) | 1978-07-18 | 1980-11-18 | Agar Ginosar Electronics And Metal Products | Apparatus and method for controlling pain by transcutaneous electrical stimulation (TES) |
| US4305402A (en) | 1979-06-29 | 1981-12-15 | Katims Jefferson J | Method for transcutaneous electrical stimulation |
| US4635641A (en) | 1985-10-16 | 1987-01-13 | Murray Electronics Associates Limited | Multi-element electrode |
| SU1718976A1 (ru) | 1989-10-31 | 1992-03-15 | 1-Й Московский Медицинский Институт Им.И.М.Сеченова | Способ купировани болей при невралгии тройничного нерва |
| RU2086227C1 (ru) | 1994-04-05 | 1997-08-10 | Российский научно-исследовательский нейрохирургический институт им.проф.А.Л.Поленова | Способ лечения поражений нервно-сосудистых структур орбиты |
| JPH07289649A (ja) | 1994-04-22 | 1995-11-07 | Hayashibara Takeshi | 眼神経の刺激信号発生装置 |
| US5540734A (en) * | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
| US5514175A (en) * | 1994-11-09 | 1996-05-07 | Cerebral Stimulation, Inc. | Auricular electrical stimulator |
| US5549734A (en) | 1995-03-08 | 1996-08-27 | Astec Industries, Inc. | Baghouse cleaning method |
| JPH08299141A (ja) | 1995-05-08 | 1996-11-19 | Mori Mihoko | 枕カバー |
| US5814095A (en) * | 1996-09-18 | 1998-09-29 | Implex Gmbh Spezialhorgerate | Implantable microphone and implantable hearing aids utilizing same |
| US6016449A (en) | 1997-10-27 | 2000-01-18 | Neuropace, Inc. | System for treatment of neurological disorders |
| US20070060975A1 (en) | 1999-07-08 | 2007-03-15 | Mannheimer Jeffrey S | Combination electrode-battery and programming assembly for a miniature wireless transcutaneous electrical neuro or muscular-stimulation unit |
| US7200446B2 (en) | 1999-07-21 | 2007-04-03 | Borkan William N | Catheter leads for the intrathecal space and method of use |
| US6567702B1 (en) | 1999-10-15 | 2003-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | Eliciting analgesia by transcranial electrical stimulation |
| US6466822B1 (en) | 2000-04-05 | 2002-10-15 | Neuropace, Inc. | Multimodal neurostimulator and process of using it |
| US6405079B1 (en) * | 2000-09-22 | 2002-06-11 | Mehdi M. Ansarinia | Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions |
| US7158832B2 (en) | 2000-09-27 | 2007-01-02 | Cvrx, Inc. | Electrode designs and methods of use for cardiovascular reflex control devices |
| US6549808B1 (en) | 2000-10-19 | 2003-04-15 | Heinz R. Gisel | Devices and methods for the transcutaneous delivery of ions and the electrical stimulation of tissue and cells at targeted areas in the eye |
| US6950707B2 (en) | 2000-11-21 | 2005-09-27 | Advanced Bionics Corporation | Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion |
| RU2185092C1 (ru) | 2000-12-21 | 2002-07-20 | Ремнев Андрей Геннадьевич | Способ диагностики поражения первой и второй ветвей тройничного нерва |
| US6735475B1 (en) | 2001-01-30 | 2004-05-11 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain |
| US6788975B1 (en) | 2001-01-30 | 2004-09-07 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy |
| US20060064140A1 (en) | 2001-01-30 | 2006-03-23 | Whitehurst Todd K | Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder |
| US7171276B2 (en) | 2001-06-29 | 2007-01-30 | Abbott Laboratories | Hydrogel and scrim assembly for use with electro-acupuncture device with stimulation electrodes |
| US20030045922A1 (en) | 2001-08-29 | 2003-03-06 | Nancy Northrop | Skin treatment method and apparatus |
| US20140046407A1 (en) | 2001-08-31 | 2014-02-13 | Bio Control Medical (B.C.M.) Ltd. | Nerve stimulation techniques |
| US8565896B2 (en) | 2010-11-22 | 2013-10-22 | Bio Control Medical (B.C.M.) Ltd. | Electrode cuff with recesses |
| US6954668B1 (en) | 2001-10-11 | 2005-10-11 | Cuozzo John W | Apparatus and method for intra-oral stimulation of the trigeminal nerve |
| US7689277B2 (en) | 2002-03-22 | 2010-03-30 | Leptos Biomedical, Inc. | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
| US20030195588A1 (en) * | 2002-04-16 | 2003-10-16 | Neuropace, Inc. | External ear canal interface for the treatment of neurological disorders |
| US7003352B1 (en) * | 2002-05-24 | 2006-02-21 | Advanced Bionics Corporation | Treatment of epilepsy by brain stimulation |
| JP2003339884A (ja) * | 2002-05-31 | 2003-12-02 | Fes:Kk | 顔面電気刺激装置 |
| US7158834B2 (en) | 2002-06-13 | 2007-01-02 | Atlantic Medical, Inc. | Method and apparatus for performing microcurrent stimulation (MSC) therapy |
| US7702395B2 (en) | 2002-08-19 | 2010-04-20 | Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf Of Arizona State University | Neurostimulator |
| US20040138097A1 (en) | 2002-11-01 | 2004-07-15 | Bahman Guyuron | Method and treatment for treating and preventing pain associated with compression of a nerve |
| US20040243207A1 (en) | 2003-05-30 | 2004-12-02 | Olson Donald R. | Medical implant systems |
| US8190248B2 (en) | 2003-10-16 | 2012-05-29 | Louisiana Tech University Foundation, Inc. | Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto |
| WO2005062829A2 (en) | 2003-12-19 | 2005-07-14 | Advanced Bionics Corporation | Skull-mounted electrical stimulation system and method for treating patients |
| CA2553901C (en) | 2004-01-22 | 2015-01-20 | Rehabtronics Inc. | Method of routing electrical current to bodily tissues via implanted passive conductors |
| US7844344B2 (en) | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable lead |
| US7565197B2 (en) | 2004-06-18 | 2009-07-21 | Medtronic, Inc. | Conditional requirements for remote medical device programming |
| EP1786510A4 (en) | 2004-07-15 | 2009-12-02 | Northstar Neuroscience Inc | SYSTEMS AND METHOD FOR INCREASING OR INFLUENCING THE EFFICIENCY OR EFFECTIVENESS OF NEURAL STIMULATION |
| US20060050912A1 (en) * | 2004-09-09 | 2006-03-09 | Earcraft, Inc. | Shell and tip for hearing aid |
| WO2006034305A2 (en) | 2004-09-21 | 2006-03-30 | University Of Florida Research Foundation, Inc. | Multiple lead method for deep brain stimulation |
| JP2008516696A (ja) * | 2004-10-18 | 2008-05-22 | ルイジアナ テック ユニバーシティ ファウンデーション | 神経障害の検出、予防および／または治療のための医療装置ならびにその医療装置に関連する方法 |
| US7685817B2 (en) | 2004-10-18 | 2010-03-30 | Ceti, Inc. | Method and system for providing a rotational output using a non-combustion heat source |
| US8239029B2 (en) | 2004-10-21 | 2012-08-07 | Advanced Neuromodulation Systems, Inc. | Stimulation of the amygdalohippocampal complex to treat neurological conditions |
| FR2877583B1 (fr) | 2004-11-10 | 2007-05-11 | Patrick Cosson | Dispositif d'electrotherapie |
| EP1671670A1 (fr) | 2004-12-14 | 2006-06-21 | STX Sprl | Appareil pour l'electro-inhibition des muscles de la face |
| US8825166B2 (en) | 2005-01-21 | 2014-09-02 | John Sasha John | Multiple-symptom medical treatment with roving-based neurostimulation |
| DE102005003735B4 (de) * | 2005-01-26 | 2008-04-03 | Cerbomed Gmbh | Vorrichtung zur transkutanen Stimulation eines Nervs des menschlichen Körpers |
| US8700163B2 (en) | 2005-03-04 | 2014-04-15 | Cyberonics, Inc. | Cranial nerve stimulation for treatment of substance addiction |
| EP2412306B1 (en) | 2005-03-09 | 2017-08-30 | DELTA, Dansk Elektronik, Lys & Akustik | A three-dimensional adhesive device having a microelectronic system embedded therein |
| US20060206165A1 (en) | 2005-03-14 | 2006-09-14 | Jaax Kristen N | Occipital nerve stimulation to treat headaches and other conditions |
| US7853321B2 (en) | 2005-03-14 | 2010-12-14 | Boston Scientific Neuromodulation Corporation | Stimulation of a stimulation site within the neck or head |
| US7702385B2 (en) | 2005-11-16 | 2010-04-20 | Boston Scientific Neuromodulation Corporation | Electrode contact configurations for an implantable stimulator |
| US8265758B2 (en) | 2005-03-24 | 2012-09-11 | Metacure Limited | Wireless leads for gastrointestinal tract applications |
| US7499752B2 (en) | 2005-07-29 | 2009-03-03 | Cyberonics, Inc. | Selective nerve stimulation for the treatment of eating disorders |
| US20070025608A1 (en) | 2005-07-29 | 2007-02-01 | Cyberonics, Inc. | Enhancing intrinsic neural activity using a medical device to treat a patient |
| JP2007054299A (ja) * | 2005-08-24 | 2007-03-08 | Sharp Corp | 電気治療装置、およびそれを構成するためのシステム |
| JP2007061267A (ja) * | 2005-08-30 | 2007-03-15 | Nova Medico:Kk | 鼻炎又は結膜炎治療器具 |
| US20070150027A1 (en) * | 2005-12-22 | 2007-06-28 | Rogers Lesco L | Non-invasive device and method for electrical stimulation of neural tissue |
| US8725243B2 (en) | 2005-12-28 | 2014-05-13 | Cyberonics, Inc. | Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
| US20070173908A1 (en) * | 2006-01-20 | 2007-07-26 | Cyberonics, Inc. | Transcutaneous trigeminal nerve stimulation to treat motion sickness |
| EP1979040B1 (en) | 2006-01-23 | 2009-09-02 | Koninklijke Philips Electronics N.V. | Improved biomedical electrode for extended patient wear featuring a tap, or snap, which is isolated from the retention seal |
| US7801601B2 (en) * | 2006-01-27 | 2010-09-21 | Cyberonics, Inc. | Controlling neuromodulation using stimulus modalities |
| GB0603464D0 (en) | 2006-02-21 | 2006-04-05 | Goreszeniuk Teodor | Improvements in & relating to external neurostimulation |
| EP2026874B1 (en) | 2006-03-29 | 2015-05-20 | Dignity Health | Vagus nerve stimulation system |
| WO2007136726A2 (en) | 2006-05-18 | 2007-11-29 | Ndi Medical, Llc | Portable assemblies, systems, and methods for providing functional or therapeutic neurostimulation |
| US20080128215A1 (en) | 2006-05-24 | 2008-06-05 | Gershon Nowitz | Portable Scissor Lift |
| US8909342B2 (en) | 2006-08-15 | 2014-12-09 | Andres M. Lozano | Method for treating eating disorders |
| US7940933B2 (en) | 2006-08-18 | 2011-05-10 | Medtronic, Inc. | Secure telemetric link |
| US7774072B2 (en) | 2006-11-30 | 2010-08-10 | Medtronic, Inc. | Attached implantable medical elongated members |
| US20080140151A1 (en) | 2006-12-11 | 2008-06-12 | Brodkey Jason A | Nerve stimulation apparatus and method for the treatment of head pain |
| US7890178B2 (en) * | 2006-12-15 | 2011-02-15 | Medtronic Xomed, Inc. | Method and apparatus for assisting deglutition |
| US9913593B2 (en) | 2006-12-27 | 2018-03-13 | Cyberonics, Inc. | Low power device with variable scheduling |
| US8696724B2 (en) * | 2007-01-11 | 2014-04-15 | Scion Neurostim, Llc. | Devices for vestibular or cranial nerve stimulation |
| US20080171929A1 (en) | 2007-01-11 | 2008-07-17 | Katims Jefferson J | Method for standardizing spacing between electrodes, and medical tape electrodes |
| JP4961558B2 (ja) * | 2007-03-30 | 2012-06-27 | 国立大学法人信州大学 | 三叉神経固有知覚枝刺激装置 |
| WO2008128215A1 (en) | 2007-04-13 | 2008-10-23 | Alejandro Covalin | Apparatus and method for the treatment of headache |
| US20080262566A1 (en) | 2007-04-23 | 2008-10-23 | Boston Scientific Neuromodulation Corporation | Methods and systems of treating medication overuse headache |
| US8954162B2 (en) | 2007-04-25 | 2015-02-10 | Medtronic, Inc. | Medical device implantation |
| EP2164389B1 (en) | 2007-07-06 | 2013-06-19 | Koninklijke Philips Electronics N.V. | Shielded biomedical electrode patch |
| EP2195084A4 (en) | 2007-09-26 | 2010-10-20 | Univ Duke | METHOD FOR TREATING PARKINSON DISEASE AND OTHER MOTION FLUCTUATIONS |
| WO2009055204A1 (en) | 2007-10-24 | 2009-04-30 | Medtronic, Inc. | Transmission of power source usage information over a network |
| US8849407B1 (en) | 2008-01-04 | 2014-09-30 | Yuri P. Danilov | Non-invasive neuromodulation (NINM) for rehabilitation of brain function |
| EP2092951A1 (fr) * | 2008-02-20 | 2009-08-26 | Stx-Med Sprl | Appareil pour le traîtement électrothérapeutique des céphalées de tension |
| ES2563634T3 (es) * | 2008-05-13 | 2016-03-15 | Cerbomed Gmbh | Aparato para mejorar el funcionamiento del tejido neurológico |
| US20090326602A1 (en) | 2008-06-27 | 2009-12-31 | Arkady Glukhovsky | Treatment of indications using electrical stimulation |
| CN105126262B (zh) | 2008-07-14 | 2019-03-22 | 代理并代表亚利桑那州立大学的亚利桑那董事会 | 使用超声用于调节细胞活性的方法和装置 |
| US20100030227A1 (en) | 2008-07-31 | 2010-02-04 | Medtronic, Inc. | Medical lead implantation |
| US8512715B2 (en) | 2008-08-14 | 2013-08-20 | The Cleveland Clinic Foundation | Apparatus and method for treating a neuromuscular defect |
| EP3266498B1 (en) | 2008-10-21 | 2024-08-07 | MED-EL Elektromedizinische Geräte GmbH | System and method for facial nerve stimulation |
| US8666498B2 (en) | 2008-10-27 | 2014-03-04 | Serene Medical, Inc. | Treatment of headache |
| DE102008043973B4 (de) | 2008-11-21 | 2011-12-01 | Burkhard Brocke | Vorrichtung zur transkraniellen Neurostimulation |
| US8494641B2 (en) | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
| KR101749605B1 (ko) | 2009-10-05 | 2017-06-21 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | 신경계통 이상증상 및 신경질환의 치료를 위한 시스템, 장치 및 방법 |
| US9101766B2 (en) * | 2009-10-16 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Eliciting analgesia by transcranial electrical stimulation |
| KR20130111206A (ko) * | 2010-05-02 | 2013-10-10 | 레이크 바이오사이언스, 엘엘씨 | 안면 신경계 또는 관련 신경 구조의 기능의 귀를 통한 조절 |
| US8702584B2 (en) | 2010-05-12 | 2014-04-22 | Cefaly Technology Sprl | Neurostimulation method to induce relaxation or sleep |
| WO2012075192A2 (en) | 2010-11-30 | 2012-06-07 | The Regents Of The University Of California | Pulse generator for cranial nerve stimulation |
| KR20140037803A (ko) | 2010-12-14 | 2014-03-27 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | 의료 질환 치료용 장치, 시스템 및 방법 |
| JP6559395B2 (ja) | 2010-12-14 | 2019-08-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 医学的障害の治療のための、頭蓋外に埋め込み可能なシステム |
| US20120203301A1 (en) | 2011-02-07 | 2012-08-09 | Advanced Neuromodulation Systems, Inc. | Methods using trigeminal nerve stimulation to treat neurological diseases |
| WO2012155117A1 (en) | 2011-05-11 | 2012-11-15 | Covalin, Alejandro | Headache-treatment device with gel dispensing kit and method |
| BE1020458A3 (fr) | 2012-01-13 | 2013-10-01 | Stx Med Sprl | Appareil electronique autonome et dipositif de fixation de celui-ci sur une electrode localisee au niveau de la tete pour une utilisation en position couchee du patient. |
| KR20150014445A (ko) | 2012-04-05 | 2015-02-06 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | 뇌신경 자극용 피하 전극 |
| US20140039572A1 (en) * | 2012-08-03 | 2014-02-06 | Boston Scientific Neuromodulation Corporation | System and method for treating depression and epilepsy |
| CN204147427U (zh) | 2012-11-26 | 2015-02-11 | 塞恩克公司 | 可穿戴的皮肤电刺激设备 |
| US10220211B2 (en) * | 2013-01-22 | 2019-03-05 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
-
2011
- 2011-12-14 KR KR1020137018221A patent/KR20140037803A/ko not_active Ceased
- 2011-12-14 WO PCT/US2011/065002 patent/WO2012082960A2/en not_active Ceased
- 2011-12-14 JP JP2013544759A patent/JP6130789B2/ja active Active
- 2011-12-14 EP EP11849085.3A patent/EP2651496A4/en not_active Withdrawn
- 2011-12-14 US US13/994,541 patent/US20140135886A1/en not_active Abandoned
- 2011-12-14 CA CA2821981A patent/CA2821981C/en active Active
- 2011-12-14 AU AU2011343763A patent/AU2011343763B2/en active Active
-
2016
- 2016-09-20 JP JP2016182614A patent/JP6539240B2/ja active Active
-
2017
- 2017-01-24 AU AU2017200484A patent/AU2017200484A1/en not_active Abandoned
- 2017-07-14 US US15/650,707 patent/US10639468B2/en active Active
-
2019
- 2019-06-07 JP JP2019107209A patent/JP6856704B2/ja active Active
-
2021
- 2021-03-18 JP JP2021044199A patent/JP2021104345A/ja active Pending
-
2022
- 2022-11-29 JP JP2022189752A patent/JP2023014177A/ja active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016017954A1 (ko) * | 2014-08-01 | 2016-02-04 | (주)와이브레인 | 전기 자극 장치 |
| US10342969B2 (en) | 2014-08-01 | 2019-07-09 | Y-Brain Inc. | Electrical stimulation device |
| US11110273B2 (en) | 2014-08-01 | 2021-09-07 | Y-Brain Inc. | Electrical stimulation device |
| KR101525450B1 (ko) * | 2014-08-01 | 2015-06-03 | (주)와이브레인 | 전기 자극 장치 |
| US12220577B2 (en) | 2015-03-30 | 2025-02-11 | Cefaly Technology Sprl | Device for the transcutaneous electrical stimulation of the trigeminal nerve |
| KR20170132236A (ko) * | 2015-03-30 | 2017-12-01 | 세팔리 테크놀로지 에스피알엘 | 삼차 신경의 경피 전기 자극을 위한 장치 |
| KR20220110609A (ko) * | 2015-03-30 | 2022-08-08 | 세팔리 테크놀로지 에스피알엘 | 삼차 신경의 경피 전기 자극을 위한 장치 |
| US11433234B2 (en) | 2017-05-19 | 2022-09-06 | Cefaly Technology Sprl | External trigeminal nerve stimulation for the acute non-invasive treatment of migraine attacks |
| WO2019164076A1 (ko) * | 2018-02-23 | 2019-08-29 | 주식회사 아모랩 | 펄스 자기장을 이용한 미주신경 자극 방법 및 장치 |
| WO2022114621A1 (ko) * | 2020-11-30 | 2022-06-02 | 서울대학교산학협력단 | 부정맥 치료 장치 및 상기 부정맥 치료 장치를 이용하여 사용자의 부정맥을 치료하는 방법 |
| US12521547B2 (en) | 2020-11-30 | 2026-01-13 | Seoul National University R&Db Foundation | Arrhythmia treatment device and method for treating arrhythmia of user by using same |
| WO2023243767A1 (ko) | 2022-06-15 | 2023-12-21 | 주식회사 뉴로그린 | 자극 인가 장치 |
| KR102546063B1 (ko) | 2022-06-15 | 2023-06-21 | 주식회사 뉴로그린 | 자극 인가 장치 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20180001077A1 (en) | 2018-01-04 |
| JP2017035494A (ja) | 2017-02-16 |
| JP2019166378A (ja) | 2019-10-03 |
| JP2023014177A (ja) | 2023-01-26 |
| CA2821981A1 (en) | 2012-06-21 |
| EP2651496A2 (en) | 2013-10-23 |
| US20140135886A1 (en) | 2014-05-15 |
| JP6856704B2 (ja) | 2021-04-07 |
| EP2651496A4 (en) | 2014-07-09 |
| JP6539240B2 (ja) | 2019-07-03 |
| WO2012082960A2 (en) | 2012-06-21 |
| JP6130789B2 (ja) | 2017-05-17 |
| AU2017200484A1 (en) | 2017-02-16 |
| CA2821981C (en) | 2021-01-12 |
| US10639468B2 (en) | 2020-05-05 |
| AU2011343763B2 (en) | 2017-02-16 |
| WO2012082960A3 (en) | 2012-08-09 |
| AU2011343763A1 (en) | 2013-07-25 |
| JP2014501138A (ja) | 2014-01-20 |
| JP2021104345A (ja) | 2021-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6856704B2 (ja) | 医学的障害の治療のためのデバイス | |
| JP7541547B2 (ja) | 神経精神障害を治療するための装置、システム及び方法 | |
| US10238862B2 (en) | Extracranial implantable devices, systems and methods for the treatment of medical disorders | |
| JP2014501138A5 (https=) | ||
| JP2014501139A5 (https=) | ||
| Monaco et al. | Central effects of trigeminal electrical stimulation | |
| Tsang et al. | Invasive Electric Stimulation for Tinnitus Treatment | |
| Cooper et al. | The purpose of this report is to summarize our observations of the |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20130712 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20161214 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20181029 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20190828 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20181029 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| E601 | Decision to refuse application | ||
| E801 | Decision on dismissal of amendment | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20200102 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20181029 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| PE0801 | Dismissal of amendment |
Patent event code: PE08012E01D Comment text: Decision on Dismissal of Amendment Patent event date: 20200102 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20191122 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20190426 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20161214 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20130801 |